Biomarkers for graft-versus-host disease
US11372003B2 · kind B2 · utility
3Cited by
33References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 11, 2019 |
| Grant date | Jun 28, 2022 |
| Priority date | — |
| Expiry date | Jul 22, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/60
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Biomarkers are provided that are predictive of a subject's responsiveness to a therapy comprising a JAK inhibitor. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for a subject having, suspected of having, or at risk of developing Graft-Versus-Host Disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.